Dietlein M - Search Results

1

Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET.

Scheffler M, Kobe C, Zander T, Nogova L, Kahraman D, Thomas R, Neumaier B, Dietlein M, Wolf J. Scheffler M, et al. Among authors: dietlein m. Lung Cancer. 2012 Sep;77(3):617-20. doi: 10.1016/j.lungcan.2012.05.110. Epub 2012 Jun 20. Lung Cancer. 2012. PMID: 22726919

2

Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.

Weihrauch MR, Re D, Scheidhauer K, Ansén S, Dietlein M, Bischoff S, Bohlen H, Wolf J, Schicha H, Diehl V, Tesch H. Weihrauch MR, et al. Among authors: dietlein m. Blood. 2001 Nov 15;98(10):2930-4. doi: 10.1182/blood.v98.10.2930. Blood. 2001. PMID: 11698273 Free article.

3

Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease.

Weihrauch MR, Re D, Bischoff S, Dietlein M, Scheidhauer K, Krug B, Textoris F, Ansén S, Franklin J, Bohlen H, Wolf J, Schicha H, Diehl V, Tesch H. Weihrauch MR, et al. Among authors: dietlein m. Ann Hematol. 2002 Jan;81(1):20-5. doi: 10.1007/s00277-001-0390-y. Epub 2001 Dec 12. Ann Hematol. 2002. PMID: 11807631

4

[The incidentaloma of the thyroid. Over- or underuse of diagnostic procedure for an epidemiologic finding?].

Dietlein M, Kobe C, Schmidt M, Schicha H. Dietlein M, et al. Nuklearmedizin. 2005;44(5):213-24; quiz N41-2. Nuklearmedizin. 2005. PMID: 16395498 German.

5

[Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery].

Dietlein M, Dederichs B, Kobe C, Theissen P, Schmidt M, Schicha H. Dietlein M, et al. Nuklearmedizin. 2006;45(1):21-34; quiz N1-2. doi: 10.1267/nukl06010021. Nuklearmedizin. 2006. PMID: 16493511 Review. German.

6

Cell death induced by 131 I in a differentiated thyroid carcinoma cell line in vitro: necrosis or apoptosis?

Marx K, Moka D, Schomäcker K, Fischer T, Gabruk-Szostak B, Kobe C, Dietlein M, Schicha H. Marx K, et al. Among authors: dietlein m. Nucl Med Commun. 2006 Apr;27(4):353-8. doi: 10.1097/01.mnm.0000199475.08407.e2. Nucl Med Commun. 2006. PMID: 16531921

7

Yttrium-90 ibritumomab tiuxetan-induced complete remission in a patient with classical lymphocyte-rich Hodgkin's Lymphoma.

Schnell R, Dietlein M, Schomäcker K, Kobe C, Borchmann P, Schicha H, Hallek M, Engert A. Schnell R, et al. Among authors: dietlein m. Onkologie. 2008 Feb;31(1-2):49-51. doi: 10.1159/000111758. Epub 2008 Jan 22. Onkologie. 2008. PMID: 18268399

8

Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?

Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H. Kobe C, et al. Among authors: dietlein m. Nuklearmedizin. 2008;47(1):13-7. Nuklearmedizin. 2008. PMID: 18278207

9

Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine.

Schmidt M, Voell M, Rahlff I, Dietlein M, Kobe C, Faust M, Schicha H. Schmidt M, et al. Among authors: dietlein m. Thyroid. 2008 Jul;18(7):755-60. doi: 10.1089/thy.2008.0008. Thyroid. 2008. PMID: 18631004

10

Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?

Kobe C, Weber I, Eschner W, Sudbrock F, Schmidt M, Dietlein M, Schicha H. Kobe C, et al. Among authors: dietlein m. Nuklearmedizin. 2008;47(4):153-6. Nuklearmedizin. 2008. PMID: 18690374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters